Feng Lin

Years Active: 2017-2023
Publications (10 Years): 3

Cleveland Clinic

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cleveland Clinic

United States

PI :: Dept of Immunity and Inflammation

Publications

Neetha Parameswaran, Liping Luo, Lingjun Zhang, Joel Chen, Frank P DiFilippo, Charlie Androjna, David A Fox, Sarah L Ondrejka, Eric D Hsi, Deepa Jagadeesh, Daniel J Lindner, Feng Lin
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma. Leukemia (2023)
Lingjun Zhang, Jin Y Chen, Cassandra Kerr, Brian A Cobb, Jaroslaw P Maciejewski, Feng Lin
Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria. Leukemia 35 (4) (2020)
Lingjun Zhang, Wen Qiu, Stephen Crooke, Yan Li, Areeba Abid, Bin Xu, Neal K Devaraj, Feng Lin
Development of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo. ACS chemical biology 12 (2) (2017)

Feng Lin.css-eqlu8i{font-size:small;padding-left:4px;}